Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis
NCT01404338 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2011-07-28
Summary
Tachyphylaxis occurs when a medication is applied multiple times and a decreased response takes place. Many dermatologists believe that tachyphylaxis to topical steroids commonly occur. Other believe that tachyphylaxis can be explain by patient non-compliance with topical medications. This study is looking to prove or disprove the phenomenon of tachyphylaxis by using topical steroids in the psoriasis patient population. The investigators are looking to enroll 10 patients with symmetric, bilateral, and small psoriasis plaques. The investigators will either apply a strong topical steroid or a vehicle ointment to the plaques, which is be occluded with a band aid for a one week period. Weekly, the investigators will inspect the plaques for tachyphylaxis. This regimen will be repeated during phase 2, to see if there is change in the time to tachyphylaxis. This regimen will be repeated during phase 3, however, both plaques will be treated with steroid in this phase, and time to tachyphylaxis will be measured.
Conditions
Interventions
- DRUG
-
Halobetasol 0.05% ointment
- DRUG
-
Placebo Ointment
Sponsors & Collaborators
-
Patel, Rita Vikram, M.D.
lead INDIV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
More Related Trials
-
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
NCT01166646 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
NCT03212963 ·Status: TERMINATED ·Phase: PHASE4
-
Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
NCT02801435 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
NCT03469336 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
NCT02785185 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
NCT03004339 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
NCT00437255 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test
NCT01462643 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
NCT03992261 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
NCT00733954 ·Status: COMPLETED ·Phase: PHASE4
-
Moderate to Severe Plaque Psoriasis With Scalp Involvement
NCT00791765 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
NCT03987763 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis
NCT00715975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
NCT03069144 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
NCT06982352 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
NCT03669757 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
NCT04203433 ·Status: COMPLETED ·Phase: PHASE1
-
Tofacitinib Ointment For Chronic Plaque Psoriasis
NCT01831466 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.
NCT05282771 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis
NCT01001208 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis
NCT00625326 ·Status: COMPLETED ·Phase: PHASE2
-
Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis
NCT02340169 ·Status: COMPLETED ·Phase: PHASE4